SG153699A1 - Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions - Google Patents
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositionsInfo
- Publication number
- SG153699A1 SG153699A1 SG200719016-8A SG2007190168A SG153699A1 SG 153699 A1 SG153699 A1 SG 153699A1 SG 2007190168 A SG2007190168 A SG 2007190168A SG 153699 A1 SG153699 A1 SG 153699A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- collections
- proteome
- analyzing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44139803P | 2003-01-16 | 2003-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG153699A1 true SG153699A1 (en) | 2009-07-29 |
Family
ID=32771925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200719016-8A SG153699A1 (en) | 2003-01-16 | 2004-01-16 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
Country Status (12)
Country | Link |
---|---|
US (3) | US20060051879A9 (fr) |
EP (2) | EP2259068B1 (fr) |
JP (2) | JP4741458B2 (fr) |
AT (1) | ATE489629T1 (fr) |
AU (1) | AU2004206856B9 (fr) |
CA (2) | CA2658334C (fr) |
DE (1) | DE602004030212D1 (fr) |
DK (1) | DK2259068T3 (fr) |
HK (1) | HK1080946A1 (fr) |
IL (3) | IL169437A (fr) |
SG (1) | SG153699A1 (fr) |
WO (1) | WO2004064972A2 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2053406A3 (fr) | 2001-07-16 | 2009-06-24 | caprotec bioanalytics GmbH | Composés de capture, collections associées et procédés d'analyse protéomique et compositions complexes |
DE60325847D1 (de) * | 2002-03-11 | 2009-03-05 | Caprotec Bioanalytics Gmbh | Verbindungen und verfahren für die analyse des proteoms |
CA2658334C (fr) | 2003-01-16 | 2012-07-10 | Caprotec Bioanalytics Gmbh | Composes de capture, collections associees et methodes d'analyse du proteome et de compositions de complexes |
US20060210982A1 (en) * | 2003-01-31 | 2006-09-21 | Hiroshi Yanagawa | Cleavable assigned molecules and screening method using the same |
EP1800136B1 (fr) * | 2004-10-15 | 2011-12-07 | Danisco US Inc. | Criblage differentiel competitif |
GB0515323D0 (en) * | 2005-07-26 | 2005-08-31 | Electrophoretics Ltd | Mass labels |
US7837626B2 (en) * | 2005-08-05 | 2010-11-23 | Siemens Medical Solutions Usa, Inc. | Contrast agent manipulation with medical ultrasound imaging |
US7989160B2 (en) | 2006-02-13 | 2011-08-02 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
US8084734B2 (en) * | 2006-05-26 | 2011-12-27 | The George Washington University | Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays |
US8110796B2 (en) | 2009-01-17 | 2012-02-07 | The George Washington University | Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays |
EP2394175B1 (fr) | 2009-02-09 | 2016-02-03 | caprotec bioanalytics GmbH | Dispositifs, systèmes et procédés pour la séparation de particules magnétiques |
US20100281003A1 (en) * | 2009-04-02 | 2010-11-04 | New York University | System and uses for generating databases of protein secondary structures involved in inter-chain protein interactions |
US9490113B2 (en) | 2009-04-07 | 2016-11-08 | The George Washington University | Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry |
GB0916881D0 (en) * | 2009-09-25 | 2009-11-11 | Electrophoretics Ltd | Mass labels |
GB201014023D0 (en) | 2010-08-20 | 2010-10-06 | Ucl Business Plc | Process for producing bioconjugates and products thereof |
DE102010060498B4 (de) | 2010-11-11 | 2013-04-18 | Caprotec Bioanalytics Gmbh | Isolierung und funktionale Identifizierung ganzer Zellen |
DE102011050363A1 (de) | 2011-05-13 | 2012-11-15 | Caprotec Bioanalytics Gmbh | Stufenweise aufbaubare Fängerverbindungen und Verfahren zur Proteinisolierung aus komplexen Gemischen |
EP2812344A4 (fr) | 2012-02-07 | 2015-10-28 | Vibrant Holdings Llc | Substrats, réseaux de peptides et procédés |
EP2821489B1 (fr) * | 2012-03-02 | 2017-02-22 | Japan Science And Technology Agency | Procédé de construction de molécule d'acide nucléique fonctionnelle, et combinaison d'acides nucléiques destinée à être utilisée dans ledit procédé |
WO2013172942A1 (fr) * | 2012-05-18 | 2013-11-21 | Purdue Research Foundation | Procédés pour isoler des protéines |
ES2723885T3 (es) | 2012-07-19 | 2019-09-03 | Daiichi Sankyo Co Ltd | Anticuerpos anti-Siglec-15 |
DE102012216346A1 (de) | 2012-09-13 | 2014-03-13 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Markieren oder Immobilisieren einer Zielstruktur |
US10006909B2 (en) | 2012-09-28 | 2018-06-26 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
EP2913674A1 (fr) | 2014-02-28 | 2015-09-02 | Caprotec Bioanalytics GmbH | Composés de capture assemblés progressifs comprenant une fonction clivable et procédé pour isoler et/ou caractériser des biomolécules ou fragments de biomolécules, en particulier de protéines ou de fragments de protéines, de mélanges complexes |
CN104483445B (zh) * | 2014-12-03 | 2016-10-12 | 广东省食品药品检验所 | 一种噻唑烷二酮快速检测试剂盒及其检测方法 |
AU2016228516A1 (en) * | 2015-03-12 | 2017-09-21 | Vibrant Holdings, Llc | Polypeptide arrays and methods of attaching polypeptides to an array |
WO2017029194A1 (fr) * | 2015-08-14 | 2017-02-23 | Johannes Kepler Universität Linz | Biocapteur à régénération |
WO2018143357A1 (fr) * | 2017-02-01 | 2018-08-09 | 国立大学法人浜松医科大学 | Procédé d'analyse de substance ayant une haute affinité pour une substance cible |
US20200149034A1 (en) * | 2017-03-17 | 2020-05-14 | Hitgen Ltd. | Methods and Compositions for Synthesis of Encoded Libraries |
CN107102079A (zh) * | 2017-04-26 | 2017-08-29 | 苏州海科医药技术有限公司 | 检测人血浆中阿托伐他汀及代谢物的液相色谱‑串联质谱方法及临床药动学研究的应用 |
CN108061777B (zh) * | 2017-11-27 | 2020-05-08 | 浙江公正检验中心有限公司 | 减肥类保健食品中34种非法添加药物残留量的检测方法 |
WO2019126734A1 (fr) * | 2017-12-22 | 2019-06-27 | Pacific Biosciences Of California, Inc. | Protéines de liaison à la biotine modifiées pour l'immobilisation |
AU2019308231B2 (en) * | 2018-07-16 | 2022-12-22 | The Scripps Research Institute | Opioid haptens, conjugates, vaccines, and methods of generating antibodies |
CN109682912A (zh) * | 2019-01-16 | 2019-04-26 | 徐州立兴佳正医药科技有限公司 | 一种液质联用测定血浆中塞来昔布浓度的方法 |
DE102019109771B4 (de) * | 2019-04-12 | 2022-06-30 | Bruker Daltonics GmbH & Co. KG | Auswertung komplexer Massenspektrometrie-Daten von biologischen Proben |
EP3990141A1 (fr) * | 2019-06-26 | 2022-05-04 | Waters Technologies Corporation | Revêtements avec ligands d'affinité immobilisés et enzymes et leur utilisation dans des dosages de chromatographie en phase liquide |
CN114112980B (zh) * | 2022-01-24 | 2022-05-10 | 武汉宏韧生物医药股份有限公司 | 一种基于数据分析的药物组分检测方法与系统 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424819A1 (fr) * | 1989-10-23 | 1991-05-02 | Millipore Corporation | Modification réversible des composées biologiques pour leur détection, séparation et purification |
WO1998033808A2 (fr) * | 1997-02-04 | 1998-08-06 | Hubert Koster | Procede stoechiometrique reversible servant a la conjugaison de biomolecules |
WO1999012040A2 (fr) * | 1997-09-02 | 1999-03-11 | Sequenom, Inc. | Detection de polypeptides par spectroscopie de masse |
WO1999060007A2 (fr) * | 1998-05-15 | 1999-11-25 | Isis Innovation Limited | Reactif et procede |
WO2001077684A2 (fr) * | 2000-04-10 | 2001-10-18 | The Scripps Research Institute | Analyse proteomique |
Family Cites Families (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415732A (en) * | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
DE3239887A1 (de) | 1982-10-28 | 1984-05-03 | Hubert Prof. Dr. 2000 Hamburg Köster | Verfahren zur herstellung von oligonucleotiden |
DE3239888A1 (de) | 1982-10-28 | 1984-05-03 | Hubert Prof. Dr. 2000 Hamburg Köster | Verfahren zur herstellung von oligonucleosidphosphonaten |
US5198540A (en) * | 1982-10-28 | 1993-03-30 | Hubert Koster | Process for the preparation of oligonucleotides in solution |
DE3326520A1 (de) | 1983-07-22 | 1985-01-31 | Hubert Prof. Dr. 2000 Hamburg Köster | Verfahren zur definierten verknuepfung doppelhelikaler dna-fragmente mittels einer linker-dna sowie als linker-dna geeignete oligonucletide |
DE3329892A1 (de) | 1983-08-18 | 1985-03-07 | Köster, Hubert, Prof. Dr., 2000 Hamburg | Verfahren zur herstellung von oligonucleotiden |
DE3537403C2 (de) * | 1985-10-21 | 1995-06-01 | Papst Motoren Gmbh & Co Kg | Kollektorloser Gleichstrommotor mit oder für einen Lüfter |
EP0285675A1 (fr) | 1987-02-06 | 1988-10-12 | BIOSYNTECH Biochemische Synthesetechnik GmbH | Cassette d'ADN synthétique encodant une protéine artificielle ainsi que son expression |
US4923901A (en) | 1987-09-04 | 1990-05-08 | Millipore Corporation | Membranes with bound oligonucleotides and peptides |
EP0310361A3 (fr) * | 1987-09-30 | 1989-05-24 | Beckman Instruments, Inc. | Conjugat tridenté et méthode de sa mise en oeuvre |
JPS6455181U (fr) | 1987-09-30 | 1989-04-05 | ||
US5770625A (en) * | 1988-02-08 | 1998-06-23 | The Trustees Of Columbia University In The City Of New York | Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same |
US5011861A (en) | 1988-06-28 | 1991-04-30 | Millipore Corporation | Membranes for solid phase protein sequencing |
US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
JPH04178394A (ja) * | 1989-09-22 | 1992-06-25 | Mitsui Toatsu Chem Inc | イノシトール誘導体およびその製法 |
US5723286A (en) * | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
EP0550592B1 (fr) * | 1990-09-24 | 1997-01-15 | BRENT, Roger | Methodes de triage |
EP0672131B1 (fr) * | 1992-10-30 | 2003-12-17 | The General Hospital Corporation | Une nouvelle protein de controle du cycle cellulaire |
US6436635B1 (en) * | 1992-11-06 | 2002-08-20 | Boston University | Solid phase sequencing of double-stranded nucleic acids |
US6194144B1 (en) * | 1993-01-07 | 2001-02-27 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
US5605798A (en) * | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US5547835A (en) * | 1993-01-07 | 1996-08-20 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
US5512473A (en) * | 1993-01-29 | 1996-04-30 | Brent; Roger | Max-interacting proteins and related molecules and methods |
US6074823A (en) * | 1993-03-19 | 2000-06-13 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
WO1994021822A1 (fr) | 1993-03-19 | 1994-09-29 | Sequenom, Inc. | Sequençage de l'adn au moyen de la spectrometrie de masse par degradation a l'exonuclease |
EP0698792B1 (fr) | 1993-05-10 | 2003-07-02 | Nissui Pharmaceutical Co., Ltd. | Procede de dosage de plus d'un ligand immunologique, reactif de dosage et kit utilise a cet effet |
US5695941A (en) * | 1994-06-22 | 1997-12-09 | The General Hospital Corporation | Interaction trap systems for analysis of protein networks |
US6428955B1 (en) * | 1995-03-17 | 2002-08-06 | Sequenom, Inc. | DNA diagnostics based on mass spectrometry |
CA2218188A1 (fr) | 1995-04-11 | 1996-10-17 | Trustees Of Boston University | Sequencage de biopolymeres en phase solide |
NZ306767A (en) * | 1995-04-11 | 2000-03-27 | Univ Johns Hopkins | Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems |
US5961923A (en) * | 1995-04-25 | 1999-10-05 | Irori | Matrices with memories and uses thereof |
US5741462A (en) * | 1995-04-25 | 1998-04-21 | Irori | Remotely programmable matrices with memories |
US5751629A (en) * | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
US5925562A (en) * | 1995-04-25 | 1999-07-20 | Irori | Remotely programmable matrices with memories |
US6017496A (en) * | 1995-06-07 | 2000-01-25 | Irori | Matrices with memories and uses thereof |
US6025129A (en) * | 1995-04-25 | 2000-02-15 | Irori | Remotely programmable matrices with memories and uses thereof |
US5874214A (en) * | 1995-04-25 | 1999-02-23 | Irori | Remotely programmable matrices with memories |
US5532379A (en) * | 1995-05-05 | 1996-07-02 | Pierce Chemical Company | Biotin containing heterobifunctional cleavable compounds |
US5625184A (en) * | 1995-05-19 | 1997-04-29 | Perseptive Biosystems, Inc. | Time-of-flight mass spectrometry analysis of biomolecules |
US5777888A (en) * | 1995-08-09 | 1998-07-07 | Regents Of The University Of California | Systems for generating and analyzing stimulus-response output signal matrices |
AU6456496A (en) | 1995-08-17 | 1997-03-12 | Hybridon, Inc. | Apparatus and process for multi-stage solid-phase synthesis of long-chained organic molecules |
US5807525A (en) * | 1995-08-17 | 1998-09-15 | Hybridon, Inc. | Apparatus and process for multi stage solid phase synthesis of long chained organic molecules |
US6146854A (en) * | 1995-08-31 | 2000-11-14 | Sequenom, Inc. | Filtration processes, kits and devices for isolating plasmids |
US5654545A (en) * | 1995-09-19 | 1997-08-05 | Bruker-Franzen Analytik Gmbh | Mass resolution in time-of-flight mass spectrometers with reflectors |
US5641959A (en) * | 1995-12-21 | 1997-06-24 | Bruker-Franzen Analytik Gmbh | Method for improved mass resolution with a TOF-LD source |
US5742049A (en) * | 1995-12-21 | 1998-04-21 | Bruker-Franzen Analytik Gmbh | Method of improving mass resolution in time-of-flight mass spectrometry |
WO1997033169A1 (fr) | 1996-03-08 | 1997-09-12 | Smithkline Beecham Corporation | Methode pour determiner l'affinite des proteines a l'egard des agents chimiques lors du criblage des bibliotheques combinatoires |
WO1997037041A2 (fr) | 1996-03-18 | 1997-10-09 | Sequenom, Inc. | Sequençage d'adn par spectrometrie de masse |
AU739256B2 (en) | 1996-04-08 | 2001-10-04 | Glaxo Group Limited | Mass-based encoding and qualitative analysis of combinatorial libraries |
ES2288760T3 (es) | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | Ensamblaje electrocinetico controlado por luz de particulas proximas a superficies. |
GB9609262D0 (en) | 1996-05-02 | 1996-07-03 | Isis Innovation | Peptide library and method |
US5777325A (en) * | 1996-05-06 | 1998-07-07 | Hewlett-Packard Company | Device for time lag focusing time-of-flight mass spectrometry |
US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
US6022688A (en) | 1996-05-13 | 2000-02-08 | Sequenom, Inc. | Method for dissociating biotin complexes |
CN1173776C (zh) * | 1996-06-28 | 2004-11-03 | 卡钳技术有限公司 | 在微规模流体性设备里的高通过量的筛选分析系统 |
IL119029A0 (en) * | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
US6117631A (en) * | 1996-10-29 | 2000-09-12 | Polyprobe, Inc. | Detection of antigens via oligonucleotide antibody conjugates |
US5900481A (en) * | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
EP1460083B1 (fr) * | 1996-11-06 | 2006-01-18 | Sequenom, Inc. | Procede d'analyse et dispositif |
AU735416B2 (en) * | 1996-11-06 | 2001-07-05 | Sequenom, Inc. | Dna diagnostics based on mass spectrometry |
DE19782097T1 (de) | 1996-11-06 | 1999-10-14 | Sequenom Inc | Zusammensetzungen und Verfahren zur Immobilisierung von Nucleinsäuren an feste Träger |
US6133436A (en) * | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
US6024925A (en) * | 1997-01-23 | 2000-02-15 | Sequenom, Inc. | Systems and methods for preparing low volume analyte array elements |
US6140053A (en) * | 1996-11-06 | 2000-10-31 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
US5812272A (en) * | 1997-01-30 | 1998-09-22 | Hewlett-Packard Company | Apparatus and method with tiled light source array for integrated assay sensing |
JP2002507197A (ja) * | 1997-05-30 | 2002-03-05 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換チオピリジン |
NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
EP0990051A1 (fr) * | 1997-07-07 | 2000-04-05 | Florida State University | Identification de cibles moleculaires |
EP1003910A1 (fr) | 1997-07-22 | 2000-05-31 | Rapigene, Inc. | Fonctionnalites multiples a l'interieur d'un element matriciel et utilisations en decoulant |
US5972639A (en) * | 1997-07-24 | 1999-10-26 | Irori | Fluorescence-based assays for measuring cell proliferation |
GB9718129D0 (en) * | 1997-08-27 | 1997-10-29 | Isis Innovation | Branched structures |
JP3232052B2 (ja) * | 1997-10-31 | 2001-11-26 | 松下電器産業株式会社 | 画像復号化方法 |
US5922617A (en) * | 1997-11-12 | 1999-07-13 | Functional Genetics, Inc. | Rapid screening assay methods and devices |
US6268131B1 (en) | 1997-12-15 | 2001-07-31 | Sequenom, Inc. | Mass spectrometric methods for sequencing nucleic acids |
US6083682A (en) * | 1997-12-19 | 2000-07-04 | Glaxo Group Limited | System and method for solid-phase parallel synthesis of a combinatorial collection of compounds |
ATE304591T1 (de) | 1997-12-19 | 2005-09-15 | Hk Pharmaceuticals Inc | Nicht-bakterielles klonierungssystem zur verabreichung und expression von nukleinsäuren |
IL138668A0 (en) | 1998-04-03 | 2001-10-31 | Phylos Inc | Addressable protein arrays |
US7094943B2 (en) | 1998-04-27 | 2006-08-22 | Hubert Köster | Solution phase biopolymer synthesis |
US6723564B2 (en) | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
ATE253126T1 (de) | 1998-08-25 | 2003-11-15 | Univ Washington | Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen |
US6225061B1 (en) * | 1999-03-10 | 2001-05-01 | Sequenom, Inc. | Systems and methods for performing reactions in an unsealed environment |
US6629040B1 (en) * | 1999-03-19 | 2003-09-30 | University Of Washington | Isotope distribution encoded tags for protein identification |
US20020009394A1 (en) | 1999-04-02 | 2002-01-24 | Hubert Koster | Automated process line |
US6391649B1 (en) * | 1999-05-04 | 2002-05-21 | The Rockefeller University | Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy |
AU784501B2 (en) * | 1999-09-03 | 2006-04-13 | Yale University | Method to identify gene function using small molecule probes |
WO2001018627A2 (fr) * | 1999-09-06 | 2001-03-15 | National University Of Singapore | Procede et appareil de detection informatique automatisee de proteines et acides nucleiques cibles d'un compose chimique |
AU776811C (en) | 1999-10-13 | 2005-07-28 | Agena Bioscience, Inc. | Methods for generating databases and databases for identifying polymorphic genetic markers |
EP1138781A3 (fr) | 2000-03-31 | 2004-07-14 | Health Research, Inc. | Méthode pour la quantification de l'activité de liaison des protéines de liaison d'ADN |
AU2001257091A1 (en) * | 2000-04-18 | 2001-10-30 | Gilead Sciences, Inc. | Aptamer based two-site binding assay |
AU2001265092A1 (en) * | 2000-06-02 | 2001-12-17 | Regents Of The University Of California | Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
WO2001096607A2 (fr) | 2000-06-13 | 2001-12-20 | The Trustees Of Boston University | Utilisation d'analogues nucleotidiques dans l'analyse de melanges d'oligonucleotides et le sequençage hautement multiplexe d'acides nucleiques |
EP1309855A2 (fr) * | 2000-08-14 | 2003-05-14 | Isis Innovation Limited | Spectrometrie de masse |
US6531297B2 (en) | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
JP2004534519A (ja) * | 2000-11-17 | 2004-11-18 | アルフレッド イー. スランツ | 標的分子機能の決定と薬物リード化合物の同定に関する方法 |
US6797523B2 (en) * | 2000-11-30 | 2004-09-28 | Affinium Pharmaceuticals, Inc. | Methods for systematic identification of protein—protein interactions |
US7091046B2 (en) | 2000-12-11 | 2006-08-15 | Hk Pharmaceuticals, Inc. | Multiplexed protein expression and activity assay |
US6887667B2 (en) | 2000-12-28 | 2005-05-03 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Method and apparatus to identify small variations of biomolecules |
AU2002247097A1 (en) * | 2001-02-05 | 2002-08-19 | Activx Biosciences, Inc. | Activity based probe analysis |
US7179655B2 (en) * | 2001-03-02 | 2007-02-20 | Activx Biosciences, Inc. | Protein profiling platform |
DE60237810D1 (de) | 2001-04-03 | 2010-11-11 | Thermo Finnigan Llc | Zur vereinfachung komplexer peptidgemische geeignete verfahren und kits |
US20020146684A1 (en) * | 2001-04-09 | 2002-10-10 | Meldal Morten Peter | One dimensional unichemo protection (UCP) in organic synthesis |
US7045296B2 (en) | 2001-05-08 | 2006-05-16 | Applera Corporation | Process for analyzing protein samples |
US7183116B2 (en) * | 2001-05-14 | 2007-02-27 | The Institute For Systems Biology | Methods for isolation and labeling of sample molecules |
GB0116143D0 (en) | 2001-07-02 | 2001-08-22 | Amersham Pharm Biotech Uk Ltd | Chemical capture reagent |
EP2053406A3 (fr) * | 2001-07-16 | 2009-06-24 | caprotec bioanalytics GmbH | Composés de capture, collections associées et procédés d'analyse protéomique et compositions complexes |
EP1319954A1 (fr) | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Methodes d'analyse des protéines qui utilisent des reseaux de capture |
US20030157575A1 (en) * | 2002-01-28 | 2003-08-21 | Shane Climie | Chemical proteomics |
US20030166007A1 (en) * | 2002-01-28 | 2003-09-04 | Mds Proteomics Inc. | Chemical proteomics |
DE60325847D1 (de) | 2002-03-11 | 2009-03-05 | Caprotec Bioanalytics Gmbh | Verbindungen und verfahren für die analyse des proteoms |
WO2003102018A2 (fr) * | 2002-06-03 | 2003-12-11 | The Institute For Systems Biology | Procedes d'analyse proteomique quantitative de glycoproteines |
US7655433B2 (en) * | 2002-06-04 | 2010-02-02 | The Institute For Systems Biology | Methods for high-throughput and quantitative proteome analysis |
HUP0202212A2 (hu) * | 2002-07-10 | 2004-04-28 | Comgenex Rt. | Új kombinatorikus fehérjemarker molekulakönyvtárak, eljárás azok előállítására és alkalmazására |
US7473535B2 (en) * | 2002-08-20 | 2009-01-06 | The Institute For Systems Biology | Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
US7135288B2 (en) * | 2002-09-27 | 2006-11-14 | Ut-Battelle, Llc | Combinatorial synthesis of ceramic materials |
CA2658334C (fr) | 2003-01-16 | 2012-07-10 | Caprotec Bioanalytics Gmbh | Composes de capture, collections associees et methodes d'analyse du proteome et de compositions de complexes |
MXPA06013502A (es) * | 2004-05-21 | 2007-03-01 | Univ California | Metodo para mejorar la produccion de compuestos isoprenoides. |
AU2006259224B2 (en) | 2005-06-16 | 2012-08-23 | Mohammed Saeed | Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent |
-
2004
- 2004-01-16 CA CA2658334A patent/CA2658334C/fr not_active Expired - Fee Related
- 2004-01-16 US US10/760,085 patent/US20060051879A9/en not_active Abandoned
- 2004-01-16 AU AU2004206856A patent/AU2004206856B9/en not_active Ceased
- 2004-01-16 AT AT04702919T patent/ATE489629T1/de not_active IP Right Cessation
- 2004-01-16 DE DE602004030212T patent/DE602004030212D1/de not_active Expired - Lifetime
- 2004-01-16 EP EP10179588.8A patent/EP2259068B1/fr not_active Expired - Lifetime
- 2004-01-16 WO PCT/US2004/001037 patent/WO2004064972A2/fr active Application Filing
- 2004-01-16 JP JP2006500969A patent/JP4741458B2/ja not_active Expired - Fee Related
- 2004-01-16 EP EP04702919A patent/EP1583972B1/fr not_active Expired - Lifetime
- 2004-01-16 CA CA002513549A patent/CA2513549C/fr not_active Expired - Fee Related
- 2004-01-16 SG SG200719016-8A patent/SG153699A1/en unknown
- 2004-01-16 DK DK10179588.8T patent/DK2259068T3/da active
-
2005
- 2005-06-28 IL IL169437A patent/IL169437A/en active IP Right Grant
-
2006
- 2006-02-24 HK HK06102548.7A patent/HK1080946A1/xx not_active IP Right Cessation
-
2007
- 2007-11-08 JP JP2007290981A patent/JP4842914B2/ja not_active Expired - Fee Related
- 2007-11-22 IL IL187592A patent/IL187592A/en active IP Right Grant
-
2010
- 2010-02-26 US US12/660,511 patent/US9034798B2/en not_active Expired - Fee Related
- 2010-04-07 US US12/798,624 patent/US20100298168A1/en not_active Abandoned
- 2010-04-28 IL IL205388A patent/IL205388A0/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424819A1 (fr) * | 1989-10-23 | 1991-05-02 | Millipore Corporation | Modification réversible des composées biologiques pour leur détection, séparation et purification |
WO1998033808A2 (fr) * | 1997-02-04 | 1998-08-06 | Hubert Koster | Procede stoechiometrique reversible servant a la conjugaison de biomolecules |
WO1999012040A2 (fr) * | 1997-09-02 | 1999-03-11 | Sequenom, Inc. | Detection de polypeptides par spectroscopie de masse |
WO1999060007A2 (fr) * | 1998-05-15 | 1999-11-25 | Isis Innovation Limited | Reactif et procede |
WO2001077684A2 (fr) * | 2000-04-10 | 2001-10-18 | The Scripps Research Institute | Analyse proteomique |
Non-Patent Citations (1)
Title |
---|
TRITYL TAGS FOR ENCODING IN COMBINATORIAL SYNTHESIS * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG153699A1 (en) | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | |
WO2003092581A3 (fr) | Composes de capture, recueils de ceux-ci et procedes d'analyse du proteome et compositions complexes | |
AU2003224674A8 (en) | Compounds and methods for analyzing the proteome | |
GB2430794A (en) | Method and apparatus for identifying proteins in mixtures | |
DE60236159D1 (de) | Methode zur trennung von komponenten eines gemisches | |
AU2003254093A1 (en) | Methods for mass spectrometry analysis utilizing an integrated microfluidics sample platform | |
WO2001058925A3 (fr) | Separation et affichage de proteines | |
AU2003259029A1 (en) | Methods for high throughput and quantitative proteome analysis | |
WO2005067582A3 (fr) | Procedes et appareil pour identification d'echantillons amelioree utilisant des techniques analytiques combinees | |
HK1143862A1 (en) | Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis | |
WO2004111636A3 (fr) | Ensembles de peptides et leurs utilisations | |
WO2009020596A3 (fr) | Liquide céphalorachidien embryonnaire (e-lcr), protéines issues du e-lcr et procédés et compositions associés | |
WO2005019831A3 (fr) | Procedes pour la reduction de la complexite d'un echantillon au moyen d'anticorps a des sites antigeniques de petite dimension | |
WO2002048716A3 (fr) | Differential phage capture proteomics | |
AU2003237282A1 (en) | Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry | |
WO2004063714A3 (fr) | Procedes de detection, analyse et isolation de proteines naissantes | |
WO2002059144A3 (fr) | Marquage differentiel pour l'analyse de melanges proteiniques complexes | |
AU2174002A (en) | Method for analyzing proteins | |
WO2008008862A3 (fr) | Standards de protéomes pour la spectrométrie de masse | |
WO2002056025A3 (fr) | Procedes d'identification systematique d'interactions proteine-proteine et d'autres proprietes | |
DK1604209T3 (da) | Screeningsassay | |
WO2004001377A3 (fr) | Procedes ameliores appliques a la proteomique par capture differentielle | |
WO2006062564A3 (fr) | Procede et appareil pour reduire les erreurs d'identification positives et negatives de composes | |
WO2002057743A3 (fr) | Methodes d'analyse et de triage d'un ou de plusieurs analytes | |
WO2006020931A3 (fr) | Procede permettant de supprimer la vitamine b12 endogene et un folate dans des preparations d'albumine |